Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity
Xiaoxiao Ma, Nadeem Riaz, Robert M. Samstein, et al.
Nature Genetics (2022) Vol. 54, Iss. 7, pp. 996-1012
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Tumor microenvironment: barrier or opportunity towards effective cancer therapy
Aadhya Tiwari, Rakesh Trivedi, Shiaw‐Yih Lin
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 207
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
Víctor A. Arrieta, Crismita Dmello, Daniel J. McGrail, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 123
Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
Kailin Yang, Ahmed Halima, Timothy A. Chan
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 604-623
Closed Access | Times Cited: 107
Dissecting metastasis using preclinical models and methods
Jess D. Hebert, Joel W. Neal, Monte M. Winslow
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 391-407
Closed Access | Times Cited: 39
Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden
Mingrui Zhu, Jiwoong Kim, Qing Deng, et al.
Cancer Cell (2023) Vol. 41, Iss. 10, pp. 1731-1748.e8
Open Access | Times Cited: 30
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden
Júlia C.F. Quintanilha, Ryon P. Graf, Virginia Fisher, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2252244-e2252244
Open Access | Times Cited: 26
An immunogenetic basis for lung cancer risk
Chirag Krishna, Anniina Tervi, Miriam Saffern, et al.
Science (2024) Vol. 383, Iss. 6685
Closed Access | Times Cited: 14
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer
Margherita Ambrosini, Benoı̂t Rousseau, Paolo Manca, et al.
Annals of Oncology (2024) Vol. 35, Iss. 7, pp. 643-655
Open Access | Times Cited: 9
Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
Cristina Valero, Mahdi Golkaram, Joris L. Vos, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 19
Open Access | Times Cited: 14
The P286R mutation of DNA polymerase ε activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway
Ming Tang, Shasha Yin, Hongliang Zeng, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Molecular features and clinical actionability of gene fusions in colorectal cancer
Francesco Giulio Sullo, Simon Garinet, Hélène Blons, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 208, pp. 104656-104656
Closed Access
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape
Ashley L. Cook, Surojit Sur, Laura Dobbyn, et al.
eLife (2025) Vol. 13
Open Access
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
Stephen L. Wang, Timothy A. Chan
Cancer Cell (2025)
Closed Access
CSCO guidelines for colorectal cancer version 2024: Updates and discussions.
Liubo Chen, Hanguang Hu, Ying Yuan, et al.
PubMed (2024) Vol. 36, Iss. 3, pp. 233-239
Closed Access | Times Cited: 4
Five latent factors underlie response to immunotherapy
Joseph Usset, Axel Rosendahl Huber, Maria Andrianova, et al.
Nature Genetics (2024) Vol. 56, Iss. 10, pp. 2112-2120
Open Access | Times Cited: 4
Helicobacter pylori infection induces DNA double-strand breaks through the ACVR1/IRF3/POLD1 signaling axis to drive gastric tumorigenesis
Xinbo Xu, Fei Xiao, Huan Wang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
DNA damage repair and cancer immunotherapy
Zhiyuan Xiang, Hao Liu, Ying Hu
Genome Instability & Disease (2023) Vol. 4, Iss. 4, pp. 210-226
Closed Access | Times Cited: 9
Current Progress on Predictive Biomarkers for Response to Immune Checkpoint Inhibitors in Gastric Cancer: How to Maximize the Immunotherapeutic Benefit?
Yongqing Liu, Pengbo Hu, Liang Xu, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2273-2273
Open Access | Times Cited: 9
Prospects of POLD1 in Human Cancers: A Review
Michał Gola, Przemysław Stefaniak, Janusz Godlewski, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1905-1905
Open Access | Times Cited: 8
Biomarkers and experimental models for cancer immunology investigation
Hengyi Xu, Ziqi Jia, Fengshuo Liu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 8
Replication DNA polymerases, genome instability and cancer therapies
Juliet D. Strauss, Zachary F. Pursell
NAR Cancer (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 7
Pairwise and higher-order epistatic effects among somatic cancer mutations across oncogenesis
Jorge A. Alfaro-Murillo, Jeffrey P. Townsend
Mathematical Biosciences (2023) Vol. 366, pp. 109091-109091
Open Access | Times Cited: 7
Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway
Xufen Zheng, Yuxiang Luo, Yangjie Xiong, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e007678-e007678
Open Access | Times Cited: 7
DNA polymerase ε and δ variants drive mutagenesis in polypurine tracts in human tumors
Daria Ostroverkhova, Kathrin Tyryshkin, Annette K. Beach, et al.
Cell Reports (2024) Vol. 43, Iss. 1, pp. 113655-113655
Open Access | Times Cited: 2
Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer
Francesco Giulio Sullo, Alessandro Passardi, Chiara Gallio, et al.
(2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top